Invention Grant
- Patent Title: Cyclic deoxyribonucleotide compounds
-
Application No.: US17625498Application Date: 2020-07-15
-
Publication No.: US12110311B2Publication Date: 2024-10-08
- Inventor: Lin Zhi
- Applicant: NUCORION PHARMACEUTICALS, INC.
- Applicant Address: US CA San Diego
- Assignee: NUCORION PHARMACEUTICALS, INC.
- Current Assignee: NUCORION PHARMACEUTICALS, INC.
- Current Assignee Address: US CA San Diego
- Agency: Knobbe, Martens, Olson & Bear, LLP
- International Application: PCT/US2020/042187 2020.07.15
- International Announcement: WO2021/011692A 2021.01.21
- Date entered country: 2022-01-07
- Main IPC: C07H19/10
- IPC: C07H19/10 ; A61K31/7072 ; A61K45/06 ; A61P1/16
Abstract:
Provided herein are 5-fluorouracil derived cyclic deoxyribonucleotide compounds, their preparation and their uses, such as treating liver diseases or various types of cancer.
Public/Granted literature
- US20220298199A1 CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS Public/Granted day:2022-09-22
Information query
IPC分类:
